127 related articles for article (PubMed ID: 20843106)
1. Correlation of mast cell density, tumor angiogenesis, and clinical outcomes in patients with endometrioid endometrial cancer.
Pansrikaew P; Cheewakriangkrai C; Taweevisit M; Khunamornpong S; Siriaunkgul S
Asian Pac J Cancer Prev; 2010; 11(2):309-12. PubMed ID: 20843106
[TBL] [Abstract][Full Text] [Related]
2. Correlation of mast cell density, tumor angiogenesis, and clinical outcomes in patients with endometrioid endometrial cancer.
Pansrikaew P; Cheewakriangkrai C; Taweevisit M; Khunamornpong S; Siriaunkgul S
Asian Pac J Cancer Prev; 2010; 11(3):623-6. PubMed ID: 21039027
[TBL] [Abstract][Full Text] [Related]
3. Myometrial invasion and lymph node metastasis in endometrioid carcinomas: tumor-associated macrophages, microvessel density, and HIF1A have a crucial role.
Espinosa I; José Carnicer M; Catasus L; Canet B; D'angelo E; Zannoni GF; Prat J
Am J Surg Pathol; 2010 Nov; 34(11):1708-14. PubMed ID: 20962622
[TBL] [Abstract][Full Text] [Related]
4. Angiogenesis in endometrial carcinoma: correlation with survival and clinicopathologic risk factors.
Ozuysal S; Bilgin T; Ozan H; Kara HF; Oztürk H; Ercan I
Gynecol Obstet Invest; 2003; 55(3):173-7. PubMed ID: 12865598
[TBL] [Abstract][Full Text] [Related]
5. Tumour angiogenesis and mast cell density in the prognostic assessment of colorectal carcinomas.
Acikalin MF; Oner U; Topçu I; Yaşar B; Kiper H; Colak E
Dig Liver Dis; 2005 Mar; 37(3):162-9. PubMed ID: 15888280
[TBL] [Abstract][Full Text] [Related]
6. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
Ma SK; Zhang HT; Sun YC; Wu LY
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
[TBL] [Abstract][Full Text] [Related]
7. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
8. Tumor-associated macrophages correlate with vascular space invasion and myometrial invasion in endometrial carcinoma.
Soeda S; Nakamura N; Ozeki T; Nishiyama H; Hojo H; Yamada H; Abe M; Sato A
Gynecol Oncol; 2008 Apr; 109(1):122-8. PubMed ID: 18289648
[TBL] [Abstract][Full Text] [Related]
9. Possible involvement of adipocyte-derived leucine aminopeptidase via angiotensin II in endometrial carcinoma.
Shibata K; Kikkawa F; Mizokami Y; Kajiyama H; Ino K; Nomura S; Mizutani S
Tumour Biol; 2005; 26(1):9-16. PubMed ID: 15741767
[TBL] [Abstract][Full Text] [Related]
10. Patterns of recurrence in 1988 FIGO stage IC endometrioid endometrial cancer.
Long KC; Zhou Q; Hensley ML; Alektiar KM; Gomez J; Gardner GJ; Chi DS; Barakat RR; Abu-Rustum NR
Gynecol Oncol; 2012 Apr; 125(1):99-102. PubMed ID: 22112609
[TBL] [Abstract][Full Text] [Related]
11. [Significance of prognostic evaluation of International Federation of Gynecology and Obstetrics 2009 staging system on stage I endometrioid adenocarcinoma].
Wang ZQ; Zhang Y; Wang JL; Shen DH; Mu T; Zhao X; Yao YY; Bai Y; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):33-9. PubMed ID: 22455691
[TBL] [Abstract][Full Text] [Related]
12. Lymphovascular space invasion does not predict vaginal relapses in stage I endometrioid adenocarcinoma of the endometrium.
Desrosiers L; Fadare O; Xiao ZF; Dresser K; Wang SA
Ann Diagn Pathol; 2008 Apr; 12(2):112-7. PubMed ID: 18325471
[TBL] [Abstract][Full Text] [Related]
13. Mucinous Adenocarcinoma of the Endometrium Compared With Endometrioid Endometrial Cancer: A SEER Analysis.
Rauh-Hain JA; Vargas RJ; Clemmer J; Clark RM; Bradford LS; Growdon WB; Goodman A; Boruta DM; Schorge JO; del Carmen MG
Am J Clin Oncol; 2016 Feb; 39(1):43-8. PubMed ID: 24390270
[TBL] [Abstract][Full Text] [Related]
14. Letter to the editor in response to "Stage 1, grade 3 endometrioid adenocarcinoma of the endometrium: An analysis of clinical outcomes and patterns of recurrence".
Pollock J
Gynecol Oncol; 2010 Jun; 117(3):507; author reply 507-8. PubMed ID: 20189231
[No Abstract] [Full Text] [Related]
15. Ovarian preservation in young women with endometrial cancer of endometrioid histology.
Kinjyo Y; Kudaka W; Ooyama T; Inamine M; Nagai Y; Aoki Y
Acta Obstet Gynecol Scand; 2015 Apr; 94(4):430-4. PubMed ID: 25603833
[TBL] [Abstract][Full Text] [Related]
16. Microvessel density assessment in benign and malignant endometrial changes.
Czekierdowski A; Czekierdowska S; Czuba B; Cnota W; Sodowski K; Kotarski J; Zwirska-Korczala K
J Physiol Pharmacol; 2008 Sep; 59 Suppl 4():45-51. PubMed ID: 18955753
[TBL] [Abstract][Full Text] [Related]
17. Expression of aquaporin-1 in normal, hyperplasic, and carcinomatous endometria.
Pan H; Sun CC; Zhou CY; Huang HF
Int J Gynaecol Obstet; 2008 Jun; 101(3):239-44. PubMed ID: 18313673
[TBL] [Abstract][Full Text] [Related]
18. The long-term survival of women with surgical stage II endometrioid type endometrial cancer.
Ayhan A; Taskiran C; Celik C; Yuce K
Gynecol Oncol; 2004 Apr; 93(1):9-13. PubMed ID: 15047207
[TBL] [Abstract][Full Text] [Related]
19. Architectural versus nuclear atypia-defined FIGO grade 2 endometrial endometrioid adenocarcinoma (EEC): a clinicopathologic comparison of 154 cases with clinical follow-up.
Winham WM; Lin D; Stone PJ; Nucci MR; Quick CM
Int J Gynecol Pathol; 2014 Mar; 33(2):120-6. PubMed ID: 24487465
[TBL] [Abstract][Full Text] [Related]
20. Endoglin (CD105) expression in endometrial carcinoma.
Saad RS; Jasnosz KM; Tung MY; Silverman JF
Int J Gynecol Pathol; 2003 Jul; 22(3):248-53. PubMed ID: 12819391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]